311 results
Page 5 of 16
8-K
EX-99.1
08mtngc7sojd0ms3msm
7 May 21
GeoVax Reports 2021 First Quarter Financial Results
1:05pm
424B3
up0xrhd2g ty68o
6 May 21
Prospectus supplement
4:05pm
POS AM
l5b4xdh0o4j5j9
24 Mar 21
Prospectus update (post-effective amendment)
9:17am
8-K
EX-99.1
6muzw
23 Mar 21
GeoVax Reports 2020 Year-End Financial Results
4:35pm
8-K
EX-1.01
7qh08kf3k4oa1c8y
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
424B5
8ttqwj
11 Feb 21
Prospectus supplement for primary offering
9:17am
8-K
EX-10.1
ttjjah1lx2
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
7eyijk 6ss4
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
ekg2u2qikflb or4ch
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
to6pd6og9ymrtb1i
5 Nov 20
GeoVax Reports 2020 Third Quarter Financial Results
5:18pm
424B3
67wqeg6 xifgz0slnqly
5 Nov 20
Prospectus supplement
5:17pm
8-K
EX-10.1
dt8qb8nsivtlb2
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
424B4
reg58i33oo2p4ufemo
28 Sep 20
Prospectus supplement with pricing info
4:56pm
8-K
EX-1.1
fauf2p jc1m
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm